Market Tracker

04/17 6:05pm ET

ImmunoGen Inc (NASDAQ:IMGN)

13.99
Data as of Apr 17
 -0.22 / -1.55%
Today’s Change
11.78
Today|||52-Week Range
20.25
-4.64%
Year-to-Date

Today’s Trading

Previous close14.21
Today’s open14.19
Day’s range13.70 - 14.33
Volume1,829,858
Average volume (3 months)900,241
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+8.42%
Earnings growth (this year)+17.15%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+117.25%
P/E ratioNM
Price/Sales39.25
Price/Book9.49

Competitors

 Today’s
change
Today’s
% change
AEGRAegerion Pharmaceuti...-0.09-0.21%
OPHTOphthotech Corp-0.06-0.19%
HALOHalozyme Therapeutic...+0.02+0.26%
NVAXNovavax Inc-0.02-0.49%
Data as of 4:00pm ET, 04/17/2014

Financials

Next reporting dateMay 1, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$35.5M
Annual profit (last year)-$72.8M
Net profit margin-204.90%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts